• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

晚期肺癌患者纤维蛋白凝块特性的改变:吸烟的强烈影响。

Altered fibrin clot properties in advanced lung cancer: strong impact of cigarette smoking.

机构信息

Institute of Cardiology, Jagiellonian University Medical College, 80 Prądnicka Str. 31-202, Kraków, Poland.

Center for Research and Medical Technology, John Paul II Hospital, Pradnicka 80, 31-202, Kraków, Poland.

出版信息

Med Oncol. 2019 Mar 19;36(4):37. doi: 10.1007/s12032-019-1262-4.

DOI:10.1007/s12032-019-1262-4
PMID:30891644
Abstract

BACKGROUND

Dense fibrin networks resistant to lysis have been reported in patients at high risk of thromboembolism. Little is known about fibrin clot properties in cancer. We investigated fibrin clot properties and their determinants in patients with inoperable lung cancer.

METHODS

We enrolled 150 patients with advanced lung cancer prior to therapy and 90 control subjects matched by age, sex, cardiovascular disease, and diabetes. Plasma clot permeability (K), turbidimetric analysis of clot formation, clot lysis time (CLT), microparticle-associated tissue factor (MP-TF) activity, thrombin generation, and serum cotinine levels were determined.

RESULTS

Lung cancer patients, compared with controls, formed at a faster rate (- 8.1% lag phase) denser plasma fibrin networks (- 27.2% K) that displayed impaired lysis (+ 26.5% CLT), along with 19.5% higher MP-TF activity and 100% higher peak thrombin generated, also after adjustment for potential confounders. Cotinine levels were associated with fibrin maximum absorbance (r = 0.20, p = 0.016) and K (r = - 0.50, p < 0.0001) in cancer patients. On multivariate regression analysis, an increase in cotinine levels was a predictor of low K (the lower quartile, < 5.8 × 10 cm; odds ratio = 1.21 per 10 ng/ml, 95% confidence interval 1.02-1.46), but not CLT.

CONCLUSION

Advanced lung cancer is associated with the prothrombotic plasma clot phenotype largely driven by smoking.

摘要

背景

有报道称,高血栓栓塞风险患者的纤维蛋白网络致密且不易溶解。关于癌症患者纤维蛋白凝块特性的了解甚少。我们研究了无法手术的肺癌患者的纤维蛋白凝块特性及其决定因素。

方法

我们在治疗前招募了 150 名晚期肺癌患者和 90 名年龄、性别、心血管疾病和糖尿病相匹配的对照组。测定了血浆凝块通透性(K)、凝块形成的比浊分析、凝块溶解时间(CLT)、微粒相关组织因子(MP-TF)活性、凝血酶生成和血清可替宁水平。

结果

与对照组相比,肺癌患者的纤维蛋白网络更快形成(-8.1%的滞后期),并且纤维蛋白网络更致密(-27.2%的 K),溶解受损(CLT 增加 26.5%),同时 MP-TF 活性增加 19.5%,生成的最大凝血酶增加 100%,即使在调整了潜在混杂因素后也是如此。可替宁水平与癌症患者的纤维蛋白最大吸光度(r=0.20,p=0.016)和 K(r=-0.50,p<0.0001)呈正相关。多元回归分析显示,可替宁水平升高是 K 值降低(较低四分位数,<5.8×10 cm;比值比=每 10 ng/ml 增加 1.21,95%置信区间为 1.02-1.46)的预测因子,但不是 CLT。

结论

晚期肺癌与血栓形成前的血浆凝块表型相关,主要由吸烟引起。

相似文献

1
Altered fibrin clot properties in advanced lung cancer: strong impact of cigarette smoking.晚期肺癌患者纤维蛋白凝块特性的改变:吸烟的强烈影响。
Med Oncol. 2019 Mar 19;36(4):37. doi: 10.1007/s12032-019-1262-4.
2
Prothrombotic fibrin clot properties associated with increased endogenous thrombin potential and soluble P-selectin predict occult cancer after unprovoked venous thromboembolism.与未诱发的静脉血栓栓塞后隐匿性癌症相关的促血栓纤维蛋白凝块特性与内源性凝血酶潜力和可溶性 P 选择素增加有关。
J Thromb Haemost. 2019 Nov;17(11):1912-1922. doi: 10.1111/jth.14579. Epub 2019 Aug 8.
3
Altered fibrin clot properties in advanced lung cancer: impact of chemotherapy.晚期肺癌中纤维蛋白凝块特性的改变:化疗的影响。
J Thorac Dis. 2018 Dec;10(12):6863-6872. doi: 10.21037/jtd.2018.11.19.
4
Altered plasma fibrin clot properties in patients with digestive tract cancers: links with the increased thrombin generation.消化道癌症患者血浆纤维蛋白凝块特性的改变:与凝血酶生成增加的关系。
Thromb Res. 2013 Mar;131(3):262-7. doi: 10.1016/j.thromres.2012.11.033. Epub 2012 Dec 27.
5
Unfavorably Altered Fibrin Clot Properties in Patients with Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss Syndrome): Association with Thrombin Generation and Eosinophilia.嗜酸性肉芽肿性多血管炎(Churg-Strauss综合征)患者纤维蛋白凝块特性的不良改变:与凝血酶生成和嗜酸性粒细胞增多的关联
PLoS One. 2015 Nov 5;10(11):e0142167. doi: 10.1371/journal.pone.0142167. eCollection 2015.
6
Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation.N末端B型利钠肽原(NT-proBNP)升高与心房颤动时血浆纤维蛋白凝块特性的不良改变有关。
Int J Cardiol. 2017 Sep 15;243:244-250. doi: 10.1016/j.ijcard.2017.05.060. Epub 2017 May 16.
7
Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3days of treatment: Relation to coagulation factors and thrombin generation.维生素 K 拮抗剂可在房颤患者治疗后 3 天内即可早期改善纤维蛋白凝块特性:与凝血因子和凝血酶生成的关系。
Thromb Res. 2015 Oct;136(4):832-8. doi: 10.1016/j.thromres.2015.08.007. Epub 2015 Aug 16.
8
Altered plasma fibrin clot properties and fibrinolysis in patients with multiple myeloma.多发性骨髓瘤患者的血浆纤维蛋白凝块性质和纤维蛋白溶解改变。
Eur J Clin Invest. 2014 Jun;44(6):557-66. doi: 10.1111/eci.12269.
9
Altered Plasma Clot Properties and Trauma-Related Venous Thromboembolism despite Thromboprophylaxis.尽管进行了血栓预防,但血浆凝块特性改变与创伤相关的静脉血栓栓塞症。
Thromb Haemost. 2018 Apr;118(4):654-663. doi: 10.1055/s-0038-1636535. Epub 2018 Apr 4.
10
Altered plasma fibrin clot properties in essential thrombocythemia.原发性血小板增多症患者的血浆纤维蛋白凝块特性改变。
Platelets. 2016;27(2):110-6. doi: 10.3109/09537104.2015.1042967. Epub 2015 May 19.

引用本文的文献

1
Fibrinogen Oxidation and Thrombosis: Shaping Structure and Function.纤维蛋白原氧化与血栓形成:塑造结构与功能
Antioxidants (Basel). 2025 Mar 26;14(4):390. doi: 10.3390/antiox14040390.
2
Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial.抗血管生成药物是否会导致血栓不稳定?来自 TESEO 前瞻性登记研究和 Caravaggio 临床试验的数据。
Thromb Haemost. 2022 Oct;122(10):1653-1661. doi: 10.1055/a-1816-8347. Epub 2022 Apr 5.
3
The Relationship Between Thrombo-Inflammatory Biomarkers and Cellular Indices of Inflammation in Lymphoma Patients.

本文引用的文献

1
Altered fibrin clot properties in advanced lung cancer: impact of chemotherapy.晚期肺癌中纤维蛋白凝块特性的改变:化疗的影响。
J Thorac Dis. 2018 Dec;10(12):6863-6872. doi: 10.21037/jtd.2018.11.19.
2
Prognostic and predictive value of plasma D-dimer levels in patients with small-cell lung cancer.小细胞肺癌患者血浆 D-二聚体水平的预后和预测价值。
Int J Clin Oncol. 2018 Dec;23(6):1070-1075. doi: 10.1007/s10147-018-1320-5. Epub 2018 Aug 27.
3
Relationship between smoking and total antioxidant status, total oxidant status, oxidative stress index, vit C, vit E.
淋巴瘤患者血栓炎症生物标志物与炎症细胞指标的关系。
Clin Appl Thromb Hemost. 2021 Jan-Dec;27:10760296211050358. doi: 10.1177/10760296211050358.
4
Epigenetic underpinnings of inflammation: Connecting the dots between pulmonary diseases, lung cancer and COVID-19.炎症的表观遗传学基础:连接肺部疾病、肺癌和 COVID-19 之间的联系。
Semin Cancer Biol. 2022 Aug;83:384-398. doi: 10.1016/j.semcancer.2021.01.003. Epub 2021 Jan 20.
5
Elevated Lactate Levels in Acute Pulmonary Embolism Are Associated with Prothrombotic Fibrin Clot Properties: Contribution of NETs Formation.急性肺栓塞中乳酸水平升高与血栓前纤维蛋白凝块特性相关:中性粒细胞胞外陷阱形成的作用
J Clin Med. 2020 Mar 30;9(4):953. doi: 10.3390/jcm9040953.
吸烟与总抗氧化状态、总氧化剂状态、氧化应激指数、维生素C、维生素E之间的关系。
Clin Respir J. 2018 Jun;12(6):2006-2012. doi: 10.1111/crj.12757. Epub 2018 Jan 18.
4
Altered plasma clot properties increase the risk of recurrent deep vein thrombosis: a cohort study.改变的血浆凝块特性会增加复发性深静脉血栓形成的风险:一项队列研究。
Blood. 2018 Feb 15;131(7):797-807. doi: 10.1182/blood-2017-07-798306. Epub 2017 Dec 14.
5
Plasma fibrin clot structure and thromboembolism: clinical implications.血浆纤维蛋白凝块结构与血栓栓塞:临床意义。
Pol Arch Intern Med. 2017 Dec 22;127(12):873-881. doi: 10.20452/pamw.4165. Epub 2017 Dec 11.
6
Prothrombotic Fibrin Clot Phenotype Is Associated With Recurrent Pulmonary Embolism After Discontinuation of Anticoagulant Therapy.促血栓形成的纤维蛋白凝块表型与抗凝治疗中断后复发性肺栓塞相关。
Arterioscler Thromb Vasc Biol. 2017 Feb;37(2):365-373. doi: 10.1161/ATVBAHA.116.308253. Epub 2016 Dec 29.
7
[2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines].[欧洲心脏病学会(ESC)实践指南委员会主持制定的《2016年ESC关于癌症治疗与心血管毒性的立场文件》]
Kardiol Pol. 2016;74(11):1193-1233. doi: 10.5603/KP.2016.0156.
8
Heparins in cancer-associated venous thrombosis.肝素与癌症相关的静脉血栓形成
Pol Arch Med Wewn. 2016 Jun 23;126(6):419-29. doi: 10.20452/pamw.3449.
9
Determinants of hypofibrinolysis in patients with digestive tract cancer.消化道癌症患者纤溶功能低下的决定因素
Prz Gastroenterol. 2016;11(2):104-10. doi: 10.5114/pg.2016.57619. Epub 2016 Feb 2.
10
Risk of venous thromboembolism in people with lung cancer: a cohort study using linked UK healthcare data.肺癌患者静脉血栓栓塞的风险:一项使用英国医疗保健关联数据的队列研究。
Br J Cancer. 2016 Jun 28;115(1):115-21. doi: 10.1038/bjc.2016.143. Epub 2016 Jun 2.